Загрузка...
Appraisal of radioiodine refractory thyroid cancer: advances and challenges
The incidence of thyroid cancer ranks top among all endocrine cancers, which has increased worldwide. Some patients suffer from recurrent/residual diseases after primary treatment. The recurrent/residual disease often turns out to be radioiodine refractory and shows poor response to radioiodine ther...
Сохранить в:
| Опубликовано в: : | Am J Cancer Res |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
e-Century Publishing Corporation
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7407348/ https://ncbi.nlm.nih.gov/pubmed/32774993 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|